NuVasive Inc., which announced a move from Fairborn to West Carrollton in late 2015 as part of a $45 million expansion, recently had this banner up on its Liberty Lane plant. NICK BLIZZARD/PHOTO

With 300 local employees, NuVasive has still more openings

NuVasive Inc. has reached its full projected workforce of 300 at its West Carrollton manufacturing site and still has 35 openings, the company has said.

Motorists on Interstate 75 can easily see the hiring banner on the face of the company’s Liberty Lane facility.

“With the official close of our Fairborn site, we now have 300 employees at the NuVasive West Carrollton manufacturing facility,” the company said in a statement Wednesday.

RELATEDNuVasive CEO: West Carrollton has ‘largest and most advanced’ spinal factory

“We are continuing to hire for managerial and frontline roles in engineering, quality, functional support and manufacturing, as well as a number of internship opportunities,” the company added. “We have about 35 open positions at West Carrollton and actively recruiting for them while continuing to build a pipeline for future opportunities. We continue to look for high-quality professionals who have experience in the medical device manufacturing environment.”

Asked if there was a ceiling on expected employment at the manufacturing site, a spokesman for the San Diego-based company said he did not have an exact figure.

RELATEDDayton products play big part in Ohio manufacturing growth

NuVasive, Inc., which has a spine technology manufacturing center in West Carrollton, saw revenue rise to more than $1 billion in 2017.

For the fourth quarter of 2017, revenue remained flat at $271.7 million compared to 2016.

But the full year was strong, with revenue rising to $1,029.5 million, up seven percent.

RELATEDWest Carrollton home to ‘largest’ spinal devices factory

“2017 was a milestone year for NuVasive as we surpassed the $1 billion revenue mark driven by impressive international sales growth of more than 20 percent, and achieved record profitability of 18.2 percent non-GAAP operating margins in the fourth quarter,” Gregory Lucier, chairman and chief executive of NuVasive, said in a statement.

NuVasive reported fourth quarter 2017 total revenue of $271.7 million, edging the $271.1 million reported for the fourth quarter 2016.

RELATED: Manufacturers desperate for workers of the future

For the fourth quarter 2017, gross profit on a GAAP (Generally Accepted Accounting Principles) basis was $196.3 million and net income was reported at $24 million, or 46 cents per share.

X